INSMED Inc
Extracted from this filing and checked against the source text.
INSMED Inc shareholders approved Advisory Vote on the 2025 Compensation of Named Executive Officers at the 2026-05-13 meeting.
By the following vote, shareholders approved, on an advisory, non-binding basis, the 2025 compensation of our named executive officers, as disclosed in the Proxy Statement: For Against Abstentions Broker Non-Votes 162,133,728 23,657,325 74,398 11,564,082View on SEC.gov
INSMED Inc shareholders approved Election of Two Class II Directors at the 2026-05-13 meeting.
By the following votes, shareholders elected Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D., to serve as Class II directors until the Company’s 2029 Annual Meeting of Shareholders: For Withheld Broker Non-Votes Elizabeth McKee Anderson 153,734,471 32,130,980 11,564,082 Clarissa Desjardins, Ph.D. 164,437,828 21,427,623 11,564,082View on SEC.gov
INSMED Inc shareholders approved Ratification of the Appointment of an Independent Registered Public Accounting Firm at the 2026-05-13 meeting.
By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026: For Against Abstentions 190,386,612 6,997,613 45,308View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.